Locations:
Search IconSearch

Innovating With Clinical Intent Through Tech-Enabled Data Capture (Podcast)

The future of neurological care resides in harnessing big data sets

Biomechanics has come a long way. One of the first biomechanics studies was done to settle a bet over whether the four hooves of a galloping horse are ever all off the ground at once. Today the field has evolved to the point where common consumer electronic devices pack enough computing power to enable capture of patients’ functional data at a scale large enough to fuel disease prediction algorithms.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Jay Alberts, PhD, is a biomedical engineer at the forefront of such tech-enabled data capture. In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, he shares insights on how it is accelerating progress in biomechanics — and how it will be shaping the clinical care of patients with neurological diseases.

Dr. Alberts, Vice Chair of Innovation in Cleveland Clinic’s Neurological Institute, covers a wealth of subtopics, including:

  • Use of the iPad and other consumer electronics to objectively quantify cognitive and motor function
  • Why it’s essential to develop such tools with clear and explicit clinical intent
  • How suboptimal data quality has slowed the advancement of artificial intelligence in healthcare
  • How clinicians and engineers can best collaborate to harness technological potential

Click the player below to listen to the 17-minute podcast now, or read on below for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Alberts: We’ve done a lot around the question of how we can use consumer electronic devices to objectively quantify cognitive and motor function. I think the important part here is that we’re looking at both cognitive and motor functions simultaneously, as opposed to each in a silo. That has really led us to improve in terms of the treatment of Parkinson’s disease patients and optimizing deep brain stimulation [DBS] parameters.

So in the post-DBS setting, rather than looking at a patient just in terms of the cognitive domain and then sending them across the hall to have the neurologist do a traditional UPDRS, we’re now able to use both cognitive and motor function simultaneously to help program these patients’ DBS parameters. That’s really an important aspect because activities of daily living have both a cognitive component and a motor component, whether you’re walking across the street, carrying a cup of coffee or engaging in a conversation. You’re processing the information in terms of questions like, Is this car coming? or Are they going to stop? And then you have to monitor your motor performance as well.

Advertisement

I think that’s where we have been able to leverage some of the work we’ve done with consumer electronics to bring these types of tools to the clinic and the provider.

Advertisement

Related Articles

Physical therapist helping patient walk with a powered exoskeleton and walker

Exoskeleton-Aided Physical Therapy Proves Feasible in MS

Study looked at mobility measures and safety

portrait of Dr. Kriti Bhayana against decorative background with podcast overlay
April 2, 2026/Neurosciences/Podcast

Practice Essentials for Pediatric and Perinatal Stroke (Podcast)

Types and presentation may differ from adults, but early recognition and intervention are just as key

Two-dimensional scatter plot of peak T1 versus T2 times from pre-extended lumbar drainage MRI

MR Fingerprinting Predicts Shunt Efficacy in NPH

Study tests potential for a more accurate treatment predictor

person going into a Gamma Knife machine for radiotherapy
March 25, 2026/Neurosciences/Brain Tumor

Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma

Study uses molecular and clinical stratification to help guide patient selection

illustration of human brain with rumor at top right
March 23, 2026/Neurosciences/Brain Tumor

Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma

Phase 3 STELLAR trial underscores role of molecular stratification in glioma care

brain MRI taken from the back of the head
March 20, 2026/Neurosciences/Epilepsy

Unmasking the ‘Tethered’ Temporal Lobe: New MRI Metrics Improve Detection of Encephaloceles in Refractory Epilepsy

Early identification of temporal encephaloceles can improve surgical decision-making

brain scan with white lesion on right side

ARISE II Recommendations Chart a Course for Advancing Intracranial Hemorrhage Care

Academia, industry and government leaders develop consensus priorities

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

Ad